Geila Rozen
Corporate Officer/Principal en Rambam Medical Center .
Perfil
Geila Rozen is the founder of High Tech Lipids Ltd., which was founded in 2004.
She held the title of Clinical Researcher at the company.
Dr. Rozen's current job positions include being a Principal at Technion-Israel Institute of Technology, a Principal at The Hebrew University of Jerusalem, and a Principal at Rambam Medical Center.
Dr. Rozen obtained a doctorate degree from Technion-Israel Institute of Technology.
Cargos activos de Geila Rozen
Empresas | Cargo | Inicio |
---|---|---|
Rambam Medical Center | Corporate Officer/Principal | 19/02/2010 |
The Hebrew University of Jerusalem | Corporate Officer/Principal | 19/02/2010 |
Technion-Israel Institute of Technology | Corporate Officer/Principal | 19/02/2010 |
Antiguos cargos conocidos de Geila Rozen.
Empresas | Cargo | Fin |
---|---|---|
High Tech Lipids Ltd.
High Tech Lipids Ltd. Pharmaceuticals: MajorHealth Technology High Tech Lipids Ltd. develops lipid emulsions for infants and adults. It offers neonatal emulsions and immuno-nutrition lipids for chemotherapy patients, AIDS patients and other specific categories of surgical and critical care patients. The firm serves various sectors of the total parenteral nutrition (TPN) market, such as TPN manufacturers, healthcare providers and TPN patients. The company was founded by Geila Rozen and Irit Shochat in 2004 and is headquartered in D.N. Misgav, Israel. | Founder | - |
Formación de Geila Rozen.
Technion-Israel Institute of Technology | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
High Tech Lipids Ltd.
High Tech Lipids Ltd. Pharmaceuticals: MajorHealth Technology High Tech Lipids Ltd. develops lipid emulsions for infants and adults. It offers neonatal emulsions and immuno-nutrition lipids for chemotherapy patients, AIDS patients and other specific categories of surgical and critical care patients. The firm serves various sectors of the total parenteral nutrition (TPN) market, such as TPN manufacturers, healthcare providers and TPN patients. The company was founded by Geila Rozen and Irit Shochat in 2004 and is headquartered in D.N. Misgav, Israel. | Health Technology |
Rambam Medical Center |
- Bolsa de valores
- Insiders
- Geila Rozen